Increasing evidence suggests that the NF-κB pathway is activated in the etiology and development of head and neck squamous cell carcinomas (Liao et al., 2020; Morgan, Chen & Van Waes, 2020; Cui et al., 2022). The gene discussed is NFKB1; the disease is head and neck squamous cell carcinoma.